C12Y 603/02002
Glutamate-cysteine ligase
Official title: Glutamate-cysteine ligase (6.3.2.2)
C12Y603/02002 (Glutamate-cysteine ligase) appears on 18 US grants and 34 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 34
- Assignees
- 15
- Inventors
- 78
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 3 |
| 2017 | 0 | 3 |
| 2018 | 1 | 3 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 3 | 3 |
| 2023 | 2 | 3 |
| 2024 | 0 | 2 |
| 2025 | 4 | 4 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Glutamate-cysteine ligase variant and method for producing glutathione using same19 May 2026US 12,630,814 B2Cj Cheiljedang Corporation
- Gene related to biosynthesis of ergothioneine, and use thereof28 Apr 2026US 12,612,640 B2Shanghai Academy of Agricultural Sciences
- Method for producing gamma-glutamyl-valyl-glycine and/or a salt thereof24 Mar 2026US 12,584,157 B2Ajinomoto Co., Inc.
- Promoter and method of producing glutathione using the same23 Dec 2025US 12,503,716 B2Cj Cheiljedang Corporation
- Glutamate-cysteine ligase variant and method of producing glutathione using the same25 Nov 2025US 12,480,113 B2Cj Cheiljedang Corporation
- Compositions and methods for providing effects6 Aug 2026US 2026/0224625 A1G Tech Bio LLC
- Genome engineered yeast with high glutathione content6 Aug 2026US 2026/0226450 A1Lesaffre et Cie
- E. coli strains having an oxidative cytoplasm19 Mar 2026US 2026/0078337 A1Sutro Biopharma, Inc.
- Method for producing useful substance18 Dec 2025US 2025/0382653 A1Kaneka Corporation
- Glutamate-cysteine ligase variant and method for producing glutathione using same23 Oct 2025US 2025/0327056 A1Cj Cheiljedang Corporation
Most cited
By later US patents
- Mutant glutamate-cysteine ligase and method for manufacturing gamma glutamyl-valyl-glycine3US 10,113,161 B2Ajinomoto Co., Inc. · 2018
- Gamma glutamyl-valine synthase, and method for producing gamma glutamyl-valyl-glycine3US 10,508,295 B2Ajinomoto Co., Inc. · 2019
- Protein expression strains2US 11,130,979 B2Albumedix Ltd · 2021
- E. coli strains having an oxidative cytoplasm2US 11,407,975 B2Sutro Biopharma, Inc. · 2022
- Microorganism and method for producing gamma-glutamyl-valyl-glycine2US 11,788,109 B2Ajinomoto Co., Inc. · 2023